No dose limiting toxicity to date with outpatient administration of three doses (Days 0, 7 and 14) at total dose...
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a...
LONDON and BOSTON, June 29, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused...
Application Included Clinical Trial Data from Soft Tissue Sarcoma Patients Treated with Envafolimab in Phase 1 Trials SAN DIEGO, June...
Company plans to work with multiple microscope partners to broaden access to the CODEX® solution for single-cell, multiplexed imaging Breast...
CORAL GABLES, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company...
NE3107 Featured in the ADA’s Thought Leadership Film Series at Annual Scientific SessionSANTA MONICA, Calif., June 29, 2021 (GLOBE NEWSWIRE)...
Industry veteran promoted to oversee discovery of HiberCell’s scientific pipelineNEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology...
BRIDGEWATER, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that...
-- First BARDA Procurement has been Delivered and Revenue will be Recognized in Second Quarter 2021BOSTON, June 29, 2021 (GLOBE...
KELOWNA, British Columbia., June 29, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Statistically Significant Improvement in Pulmonary Function at Both 3 Months and 12 Months Post TreatmentTAMPA, Fla., June 29, 2021 (GLOBE...
Next-Generation Androgen Biosynthesis Inhibitor with Long Duration of Activity and Superior Therapeutic IndexPITTSBORO, N.C., June 29, 2021 (GLOBE NEWSWIRE) --...
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on...
SAN DIEGO, June 29, 2021 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted Fast Track Development...
Study will evaluate the safety and preliminary efficacy of ELI-002, an investigational lymph node-targeted therapeutic vaccine in patients with KRAS-driven...
CLN-619 will be the first MICA/B-targeted antibody to enter human clinical trialsCullinan will initiate a FIH trial in 3Q21, including...
HIGH POINT, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the...
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX- XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") announced...
NATESTO® Coverage now Includes 85% of Commercial LivesTORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a...